Saturday, December 6, 2025

Hanwha Aerospace Hits Record High as Defense Stocks Soar Amid Trump’s Tough Talk on Russia

Hanwha Aerospace hits an all-time high, driven by bullish market trends following Trump's tough stance on Russia and NATO airspace violations.

Nvidia Tapped for 1 GW AI Supercluster in UAE’s $5 Billion Stargate Project

Nvidia will supply the Grace Blackwell system for the Stargate UAE AI project, aiming to create a major AI computing cluster in Abu Dhabi.

Study Finds High-Dose Vitamin D During Pregnancy Reduces Risks of Preeclampsia and Preterm Birth

Pregnant women taking over 400 IU of vitamin D daily can lower preeclampsia risk by 44.8% and preterm birth by 30%.

Tag: Celltrion

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Bio-Revolution: Celltrion’s $700M Biosimilar Is Reshaping the Global Drug Market

Celltrion's breakthrough in antibody biosimilars is transforming healthcare, enhancing access and innovation in treatment options.

Sales and Trust: How Celltrion is Revolutionizing the European Market Directly Connected

Celltrion leverages direct sales in Europe to enhance trust and supply stability while introducing biosimilars like Omlyclo for asthma treatment.

Celltrion’s Biosimilar Success in Europe Paves the Way for a US Market Takeover

Celltrion's booth at EADV 2025 highlighted biosimilar innovations, showcasing promising clinical trial results and expanding treatment access.

Saving Poverty vs Free Trade Society? How Celltrion’s Biosimilar Could Reshape the U.S. Healthcare Market

Professor Metz highlights biosimilars' potential to expand patient access to treatments, emphasizing Omliclo's impact at EADV conference.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.